Thomas Reed work email
- Valid
- Valid
- Valid
- Valid
Thomas Reed personal email
Thomas Reed phone numbers
Thomas Reed is a senior executive with extensive experience in finance, operations, licensing, business development, management and fundraising in the biopharmaceutical and biotechnology industries. He formerly held several executive positions including at SIBIA Neurosciences (acquired by Merck), Merck & Co., Genomatica and GT Life Sciences (acquired by Intrexon). He has completed numerous financings for companies including public (IPO/NASDAQ), private investments, corporate partnerships, government grants/contracts, M&A’s, spin-outs and turnarounds and has a strong record of successful exits. Mr. Reed also has vast knowledge of intellectual property development, strategy, licensing and enforcement. He has formulated business models in diverse areas of biotechnology and, with his broad network of scientific and industry contacts, has played a key role in bringing together scientific and business teams. He has helped found and provided early investment and advisory services to a number of life science companies in the US and Europe. Mr. Reed is currently Founder & CEO of Reed-Ventures, where he provides investment and advisory services to life science companies. He also is an angel investor through NuFund Venture Group and the Keiretsu Forum.
Reed-Ventures
-
Founder/CeoReed-Ventures Jan 2001 - PresentProvides capital as well as strategic, financial and operations advisory services on the Executive and Board levels.
-
President & CfoGt Life Sciences Inc. 2008 - Nov 2011GT Life Sciences (GT) was a privately held biotechnology company that utilized a proven metabolic modeling and experimental platform to drive the discovery and design of new products and processes for the life sciences field that was sold to Intrexon in 2011. GT was a world leader in cellular metabolism, biochemical reactions, enzymatic transformations, networks and systems that control processes in cells. GT’s platform was being applied to accelerate biological research, discovery and product development for both GT and its partners in a number of commercial opportunity areas in which cellular metabolism plays an important role. -
Vice President Finance And Corporate DevelopmentGenomatica Jan 2000 - Jun 2008San Diego, Ca, UsGenomatica is the emerging leader in sustainable chemicals: ‘greener’ intermediate and basic chemicals that are made from renewable feedstocks and at lower cost. The Company's products act as direct replacements in a trillion-dollar global market that is currently based on fossil fuels.Genomatica’s technology could substantially reduce the 8% of the world’s fossil fuels used for chemical production, reduce carbon emissions by hundreds of millions of tons, and create thousands of cleantech jobs. The Company has achieved record time to pilot production of its first commercial product, 1,4-butanediol (BDO); validation of its technology through $20 million of industry and government collaborations; numerous patent filings on 20 top chemicals; and has raised over $125 million. Investors include: Alloy, Bright Capital, DFJ, MDV, Mitsubishi Capital TPG, Vantage Point and Waste Management. -
Executive DirectorMerck Sep 1999 - Mar 2000Rahway, New Jersey, Us -
Vice President And Chief Financial OfficerSibia Neurosciences, Inc. 1981 - 1999Salk Institute Biotechnology Industrial Associates (SIBIA) was acquired by Merck & Co. Inc., in November 1999. SIBIA was a publicly traded (NASDAQ) biotechnology company specializing in research, development and commercialization of therapeutics for nervous system disorders. SIBIA employed a staff of 135 consisting of highly experienced scientists and technical support staff. Joined SIBIA in 1981 as a key member of the founding staff and held progressively responsible analyst positions, which led to appointment as Manager, Business and Market Evaluation in 1988 and Director of Finance in 1991. Commencing in 1991 duties included Treasurer, Assistant Secretary, and Director of all finance, legal and administrative services including investor relations, accounting, purchasing, information services and facilities. Instrumental in identifying and securing a new CEO for the Company.
Thomas Reed Skills
Thomas Reed Education Details
-
University Of San DiegoFinance -
University Of California, BerkeleyBiology
Frequently Asked Questions about Thomas Reed
What company does Thomas Reed work for?
Thomas Reed works for Reed-Ventures
What is Thomas Reed's role at the current company?
Thomas Reed's current role is Founder and CEO at Reed-Ventures.
What is Thomas Reed's email address?
Thomas Reed's email address is tr****@****ces.com
What is Thomas Reed's direct phone number?
Thomas Reed's direct phone number is (858)-824*****
What schools did Thomas Reed attend?
Thomas Reed attended University Of San Diego, University Of California, Berkeley.
What skills is Thomas Reed known for?
Thomas Reed has skills like Start Ups, Strategy, Mergers And Acquisitions, Business Development, Due Diligence, Investor Relations, Business Strategy, Commercialization, Entrepreneurship, Product Development, Ipo, Corporate Finance.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial